Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Realty, Power stocks lead the gainers
Mon, 1 Jul 01:30 pm

Backed by persistent buying activity, Indian equity markets continued to trade strong during the post noon trading session. Barring stocks from the IT sector; all the sectoral indices are trading in the green. The most noticeable upward movement is being witnessed in the stocks of Realty and Power sector.

BSE-Sensex is up by 153 points and NSE-Nifty is trading up by 43 points. While BSE Mid Cap is trading up by 1.65%, BSE Small Cap index is trading up by 1.69%. The rupee is trading at 59.08 to the US dollar.

Majority of the FMCG stocks are trading in the green with P&G Hygiene and Lakshmi Energy being the major gainers. However, Marico and Emami are a few stocks trading in the red. As per a leading financial daily, Procter & Gamble (P&G) will be making its foray in the toothpaste segment under the Oral-B brand. Reportedly, Oral-B is the leader in the international brushing segment and is one of P&G's billion dollar brands. The company has a toothpaste portfolio under Oral-B which sells in countries such as Greece, Portugal, Israel and Venezuela. The toothpaste will be launched in the Indian market tomorrow. Colgate dominates the Indian toothpaste market with market share of 55.4%. Colgate competes with P&G in most markets across the world. Colgate is likely to increase investments behind its oral care brands in India in the light of P&G's entry. Colgate stock is currently trading down by 0.5%.

Most of the Indian pharma stocks are trading in the green with Panacea Biotech and Wockhardt Ltd leading the gainers. As per a financial daily, Cipla Ltd has received approval from takeover and regulations panel for its proposal to acquire Cipla Medpro in South Africa. The operative date of the said proposal is expected to begin from mid July. Post the acquisition, from 16th June 2013 onwards, the shares of Medpro will be delisted from Johannesburg stock exchange. Cipla and Medpro were in discussion regarding the said acquisition. In May 2013, Medpro's shareholders had given the green signal to Cipla for a 100% stake sale at US$ 488 m. Reportedly, approximately 90% of Medpro's supplies come from Cipla. Cipla was trading up by 0.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Realty, Power stocks lead the gainers". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.